
Sign up to save your podcasts
Or
Ed Livingston, MD, FACS, AGAF, discusses Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Kert Viele, PhD
4.7
1414 ratings
Ed Livingston, MD, FACS, AGAF, discusses Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Kert Viele, PhD
2,059 Listeners
321 Listeners
101 Listeners
884 Listeners
500 Listeners
38 Listeners
290 Listeners
258 Listeners
3,332 Listeners
112,335 Listeners
8 Listeners
16 Listeners
18 Listeners
13 Listeners
11 Listeners
5 Listeners
6 Listeners
9 Listeners
20 Listeners
88 Listeners
1,140 Listeners
10,224 Listeners
5 Listeners
30 Listeners
188 Listeners
5 Listeners
366 Listeners
6,043 Listeners
107 Listeners
19 Listeners
2 Listeners
163 Listeners